Profluent

About Profluent

Profluent is a company focused on authoring new biology using AI to create solutions that transform medicine, agriculture, and beyond. They aim to turn possibilities into reality by designing proteins, one at a time, to address complex challenges.

Products & Services

ProGen3:A showcased product introduced by Profluent, further details available on their platform.

OpenCRISPR:The world's first AI-designed gene editor, demonstrating authorship in gene editing.

AI-Authored Proteins:Proteins designed by AI, inspired by natural scaffolds or created from scratch, applicable in therapeutics and industrial enzymes.

Specialties

AI in protein design Gene editing Machine learning in biology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Equity Financing T: - FT: Equity Financing	A: 35000000 MR: - FA: $35M FAN: 35000000	D: 2024-03-21 FD: 2024-03-21	8 investors

Equity Financing Latest

2024-03-21

$35.0M

8 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Ali Madani

Co-founder and CEO, Profluent

F

Fraser Kelton

Profluent Advisor / Investor

J

James Fraser

Professor and Chair, Department of Bioengineering and Therapeutic Sciences, UCSF Profluent Advisor

R

Richard Socher

Former Chief Scientist Salesforce, Stanford Professor, CEO You.com, Profluent Advisor and Investor

A

Aadyot Bhatnagar

Machine Learning

A

Adeline Chen

Biology

View 30 more team members with Pro

Unlock Full Team Directory

Recent News

Profluent Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised